SSRI use and clinical outcomes in epithelial ovarian cancer

Selective serotonin reuptake inhibitor (SSRI) use is common among ovarian cancer patients. We examined the effect of SSRIs on survival and progression in ovarian cancer patients and effects of 5-HT on ovarian cancer cell (OCC) proliferation. Ovarian cancer patients from a 6-site study between 1994 a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Christensen, Desiré K., Armaiz-Pena, Guillermo N., Ramirez, Edgardo, Matsuo, Koji, Zimmerman, Bridget, Zand, Behrouz, Shinn, Eileen, Goodheart, Michael J., Bender, David, Thaker, Premal H., Ahmed, Amina, Penedo, Frank J., DeGeest, Koen, Mendez, Luis, Domann, Frederick, Sood, Anil K., Lutgendorf, Susan K.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5078084/
https://ncbi.nlm.nih.gov/pubmed/27121207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8891
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares